2020 Legal and Practical Issues in the Evolving World of Cannabis Regulation CLE
Why Attend Agenda CLE Continuing Legal Education
Why Attend Agenda CLE Continuing Legal Education
Why Attend Agenda CLE Tuesday, December 8 11:15 – 11:30 AM FDLI Welcome and Introduction Amy Comstock Rick, President & CEO, FDLI 11:30 AM –12:00 PM Fireside Chat with FDA Joseph Franklin, Policy Director for the Principal Deputy Commissioner, FDA Interviewed by Suzie Loonam Trigg, Partner, Haynes and [...]
Confirmation Thank you for your interest in FDLI committee service. Your application has been received. FDLI starts the review process after the nomination window closes on September 2025. We expect to notify all applicants of the status of their applications in December 2025. [...]
Why Attend? Agenda CLE Continuing Legal Education
Why Attend Agenda CLE Continuing Legal Education
Why Attend Agenda CLE Agenda Subject to Change. All Times are Eastern Time. Wednesday, October 28 10:55–11:10 AM Technology and Connection Support Session First virtual conference? Unsure about technology? Join FDLI staff and a Pathable Platform expert for this informal, open session to [...]
Why Attend? Agenda CLE Continuing Legal Education
Why Attend? Agenda Agenda Subject to Change. All Times are Eastern Time. CLE We are going virtual! To promote optimal interaction among attendees, the conference will feature panels with built-in audience participation and ample opportunities for attendees to connect with speakers and peers between sessions. Tuesday, [...]
Why Attend Agenda CLE Agenda Subject to Change. All Times are Eastern Time. We are going virtual! To promote optimal interaction between attendees, the conference will include ample audience participation and opportunities to connect with your peers between sessions. Digital health is revolutionizing clinical trials, [...]

Virtual Learning
Programs
Resources
Get Involved
Career
About
Fill out the form below to receive emails highlighting our upcoming programs, early registration savings, and engagement opportunities for the food and drug law community.
